Description:CGI1746, with the CAS number 910232-84-7, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is classified as a small molecule inhibitor, specifically targeting certain pathways involved in cellular signaling. The compound is known for its role in modulating biological processes, which may include effects on cell proliferation and survival. CGI1746 exhibits a specific mechanism of action that makes it a candidate for research in cancer treatment and other diseases characterized by dysregulated signaling pathways. Its chemical structure includes functional groups that contribute to its biological activity and solubility properties. As with many investigational compounds, the safety, efficacy, and pharmacokinetics of CGI1746 are subjects of ongoing research, and its full profile is still being elucidated in preclinical and clinical studies. Overall, CGI1746 represents a promising avenue for drug development, particularly in targeted therapies.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
![N-[3-[4,5-Dihydro-4-methyl-6-[[4-(4-morpholinylcarbonyl)phenyl]amino]-5-oxo-2-pyrazinyl]-2-methylp…](https://static.cymitquimica.com/products/IN/thumb/DA003A5V.jpg)
